newsfilter
← Latest News
GlobeNewswire·

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

  • SRX Global Inc. (NYSE: SRXH) acquired a stake in Vistagen Therapeutics, Inc. (NASDAQ: VTGN) on August 04, 2026.
  • Vistagen is a late clinical-stage biopharmaceutical company developing intranasal product candidates called pherines via nose-to-brain neurocircuitry for neuroscience applications.
  • SRX views Vistagen shares as undervalued & plans to engage with Vistagen's leadership team and Board to unlock shareholder value.
  • SRX Global is an AI-driven platform that uses proprietary technology & data analytics to invest in high-conviction operating companies across multiple sectors.
  • The press release includes forward-looking statements subject to risks such as transaction completion, shareholder approvals, market conditions, & regulatory considerations.